Date | Title | Description | Source |
12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAG... | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Soluti... | einpresswi... |
11.03.2024 | Patient Recruitment and Retention Services Global Market Rep... | - | globenewsw... |
07.03.2024 | Oncology-Based In-Vivo CRO Market Projected for Vigorous Gro... | - | globenewsw... |
17.08.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Auto... | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates wi... | aithority.... |
16.08.2023 | Parexel and Partex Announce Innovative Alliance Leveraging A... | Collaboration combines clinical research expertise with artificial intelligence capabilities to help... | aithority.... |
11.05.2023 | Moving Cell and Gene Therapy Trials into the Community: Chal... | Learn practical guidance and actionable insight for addressing the complexity of study start-up and ... | prweb.com/... |
16.02.2023 | Integrated Perspectives for Enhanced Rare Disease Drug Devel... | Learn how a patient-first approach can be implemented through all stages of therapy development.
TOR... | prweb.com/... |
14.10.2022 | Parexel Recognized by Frost & Sullivan with 2022 Global ... | The award recognizes Parexel for delivering the best decentralized trial experience for customers th... | en.prnasia... |
04.02.2022 | Medidata, Parexel Expands Partnership to Enhance Decentraliz... | What You Should Know:
– Medidata, a Dassault Systèmes company and Parexel, a global clinical researc... | hitconsult... |
16.11.2021 | Casper turns painful even for some of its earliest startup i... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
20.07.2021 | Parexel Commended by Frost & Sullivan for Developing a F... | The company employs real-world data and evidence to accelerate research through targeted site and pa... | en.prnasia... |
06.07.2021 | What to know about Nextdoor as it goes public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
06.07.2021 | After delay caused by Italian CDMO, Novartis moves man... | After the FDA handed Novartis a complete response letter for its PCSK9 drug inclisiran in ... | endpts.com... |
06.07.2021 | Eli Lilly, Boehringer Ingelheim tout pivotal heart fail... | The major market for chronic heart failure — until recently an indication without a sing... | endpts.com... |
06.07.2021 | Down but not out: FDA rejects Provention's diabetes drug... | In an expected and resolvable setback for Provention Bio, the FDA on Tuesday issued a compl... | endpts.com... |
06.07.2021 | What to know about Nextdoor as it goes public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
02.07.2021 | The class of molecules behind one of biotech's biggest Al... | Denovo Biopharma has spent the last decade trying to resurrect drugs that failed at other c... | endpts.com... |
02.07.2021 | Evotec expands presence in Italy with acquisition of fo... | Germany-based Evotec established its presence in Italy four years ago. Now, it’s bought up more ... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in yo... | endpts.com... |
02.07.2021 | Sartorius buys majority stake in German manufactur... | Sartorius Stedim Biotech acquired a majority stake in Germany-based CellGenix GmbH, the co... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | How is the US going to restrict the use of Biogen’s new Alzheimer’s drug so Medicare doesn’t go bank... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | When GlaxoSmithKline R&D chief Hal Barron outlined his vision for the new GSK, he touted repeate... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | The Covid-19 pandemic has kicked the contract research field into high gear, with a particular focus... | endpts.com... |
02.07.2021 | CureVac gains COO and hands Florian von der Mülbe new as... | Malte Greune
→ Aiming to bounce back and trying to accentuate the positive after its mRNA ... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | James Martin had been trying to manipulate a particular gene to regrow heart and bone cells... | endpts.com... |
02.07.2021 | Covid-19 roundup: Zydus Cadila submits 3-dose vaccine fo... | India’s second home-grown vaccine could be approved by regulators soon as Zydus Cadila ann... | endpts.com... |
02.07.2021 | Busy IPO week winds down as two more biotechs — and one look... | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmar... | endpts.com... |
02.07.2021 | A gene therapy to restore damaged tissue after a heart... | Arrowhead Pharmaceuticals faced a reckoning back in 2016 when it was forced to scrap its entire clin... | endpts.com... |
01.07.2021 | Merck to withdraw dangling accelerated approval for ... | In a first for the dangling accelerated approvals reviewed by FDA’s oncology adcomm in Ap... | endpts.com... |
01.07.2021 | Covid-19 manufacturing roundup: India starts manufac... | As India’s second wave of Covid-19 infections continues to trend downward and scientists wa... | endpts.com... |
15.04.2021 | Veeva : Parexel and Veeva Partner to Accelerate Clinical Tri... | DURHAM, N.C. and PLEASANTON, Calif., April 15, 2021 /PRNewswire/ -- Parexel and Veeva Systems (NYSE:... | marketscre... |
10.12.2020 | What’s coming up at MedCity INVEST Precision Medicine Day 3?... | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and li... | medcitynew... |
08.12.2020 | 2020 Pediatric Perceptions & Insights Study Yields Impor... | “Understanding patient health journeys and study volunteer experiences is critical to designing more... | prweb.com/... |
21.04.2020 | Initiative hopes to accelerate diagnostics and treatment for... | Medable Inc., the digital trial platform company based in Palo Alto, CA, has introduced a way to let... | techrepubl... |
07.01.2019 | PAREXEL Introduces New Dedicated Division to Help Emerging B... | BOSTON, January 7, 2019 – PAREXEL International Corporation, a leading innovator of global biopharma... | realwire.c... |
31.10.2018 | PAREXEL Navigates China's Complex Drug Development and Marke... | BOSTON, October 31, 2018 – PAREXEL International Corporation, a leading innovator of global biopharm... | realwire.c... |
09.10.2018 | PAREXEL Announces Several New Patient-Centric Innovations to... | Solutions Built on the Perceptive Cloud Platform Leverage Mobile and Wearable Technology
BOSTON, Oct... | realwire.c... |
11.09.2018 | PAREXEL Advances Patient-Centric Drug Development with Intro... | BOSTON, September 11, 2018 – PAREXEL International Corporation, a leading innovator of global biopha... | realwire.c... |
17.08.2018 | PAREXEL Announces Appointment of Two Key Executives | BOSTON, August 17, 2018 – PAREXEL International Corporation, the world’s leading innovator of biopha... | realwire.c... |
26.04.2018 | PAREXEL Announces Appointment of Peyton Howell as Chief Comm... | Proven Healthcare Industry Leader will head PAREXEL’s Commercial Strategy
BOSTON, April 26, 2018 – P... | realwire.c... |
21.03.2018 | PAREXEL Introduces Integrated Medical Writing Solutions Serv... | Comprehensive end-to-end services enable effective, streamlined communication with key stakeholders ... | realwire.c... |
13.03.2018 | PAREXEL and CHA Medical Group Partner to Enhance Early Phase... | Collaboration combines best-in-class offerings from CHA and PAREXEL to enhance early phase clinical ... | realwire.c... |
06.03.2018 | PAREXEL Appoints Jamie Macdonald as Chief Executive Officer | Company Co-founder Josef von Rickenbach to retire after 35 years of leadership; serve as Chairman of... | realwire.c... |
12.02.2018 | PAREXEL Introduces Biological Sample Lifecycle Management Se... | Solution combines global laboratory logistics expertise with leading sample tracking software to opt... | realwire.c... |
18.12.2017 | PAREXEL Announces Enhanced Global Data Operations Offering t... | Solution now features Clinical Metadata Repository to meet evolving data standards while providing s... | realwire.c... |
15.11.2017 | PAREXEL Expands Global Regulatory Services with Addition of ... | New Appointments Enhance PAREXEL’s Leadership and Expertise in Bringing Commercially Viable, Reimbur... | realwire.c... |
27.10.2017 | PAREXEL Enhances Its Active Tracking Service with Bluetooth ... | Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhone® RTSM mobile app... | realwire.c... |
24.10.2017 | Microsoft and PAREXEL form cloud technology alliance aimed a... | Companies seek to drive digital transformation of the biopharmaceutical industry by combining PAREXE... | realwire.c... |
06.09.2017 | PAREXEL Launches Real-World Data Service Offering to Drive V... | Integrated offering to be provided by new dedicated service group under PAREXEL® Access
BOSTON, Sept... | realwire.c... |
20.06.2017 | Term Sheet — Tuesday, June 20 | “I GOT A FEELING I’M OFF SCRIPT”
NEW MONEY + NEW PRODUCT: Managed by Q, a New York City-based on-dem... | fortune.co... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | venture leaders Life Science 2017: Walk the investors’ talk 20.06.2017 10:00, Lara Rossi linkedIn fa... | venturelab... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | Monday: Rolling the pitch
PAREXEL, 7:30AM. A short night after landing at Logan airport, the partici... | venturekic... |
19.06.2017 | PAREXEL introduces its Connected Journey™ of newly integrate... | Features new ForeSite™ clinical trial methodology designed to reliably predict site success
LONDON, ... | realwire.c... |
09.05.2017 | Term Sheet — Tuesday, May 9 | PROFITABILITY OVER PASSION
Land of Opportunity: Yesterday’s Term Sheet included a link to this story... | fortune.co... |
30.03.2017 | PAREXEL Launches Patient Sensor Solution To Transform Clinic... | Comprehensive wearables and sensors solution, powered by the Perceptive MyTrials® Analytics platform... | realwire.c... |
28.02.2017 | PAREXEL International appoints Simon Harford as Senior Vice ... | Appointment Effective June 1, 2017
LONDON, February 28, 2017 – PAREXEL International Corporation (NA... | realwire.c... |
13.02.2017 | PAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply... | LONDON, February 13, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global bioph... | realwire.c... |
02.02.2017 | PAREXEL Announces Definitive Agreement to Acquire The Medica... | Acquisition will strengthen and add scale to current commercialisation and medical affairs services
... | realwire.c... |
14.11.2016 | PAREXEL Launches IDMP-Focused Software And Service Solution | Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead o... | realwire.c... |
01.08.2016 | PAREXEL Appoints Four Executives to Senior Leadership Team | BOSTON, August 1, 2016 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharm... | realwire.c... |
18.12.2015 | PAREXEL Wins Best Technological Development In Clinical Tria... | LONDON, December 18, 2015 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global bioph... | realwire.c... |
15.12.2015 | PAREXEL Informatics President Named A 2016 Computerworld Pre... | LONDON, December 15, 2015 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global bioph... | realwire.c... |
01.12.2015 | PAREXEL Launches IMPACT® Express Clinical Trial Management S... | London, 1 December, 2015 — PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopha... | realwire.c... |
21.07.2015 | PAREXEL Launches Next Generation Analytics Capabilities With... | Enhancements offer clients cross-study oversight through mobile-enabled reporting and analysis
Londo... | realwire.c... |
09.07.2015 | PAREXEL Expands Model-Based Drug Development Offering | London, July 9, 2015 — PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmac... | realwire.c... |
18.06.2015 | PAREXEL Launches Next Generation Data-Driven Monitoring Capa... | Enhancements offer clients increased clinical trial efficacy and seamless data-driven monitoring exp... | realwire.c... |
08.04.2015 | PAREXEL stärkt sein globales Engagement in der Aus- und Weit... | Studiengang: Bachelor of Science in Clinical Research in Deutschland
Postgraduate-Certificate in Cli... | realwire.c... |
08.04.2015 | PAREXEL Strengthens Commitment To Global Biopharmaceutical W... | Bachelor of Science Degree in Clinical Research offered in Europe
Postgraduate Certificate in Clinic... | realwire.c... |
31.03.2015 | PAREXEL Launches LIQUENT InSight® 6.0 Regulatory Information... | London, 31 March, 2015 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharm... | realwire.c... |
18.02.2015 | PAREXEL Simplifies Patient Recruitment And Study Start-Up Ti... | Global network accelerates patient recruitment and clinical trial start-up times
London, UK, 18 Febr... | realwire.c... |
15.12.2014 | PAREXEL ClinPhone® RTSM Named Leader Of Interactive Response... | London, UK, 15 December 2014 — PAREXEL International Corporation (NASDAQ: PRXL), a leading global bi... | realwire.c... |
03.10.2014 | PAREXEL International Announces Acquisition Of ClinIntel, Ex... | London, UK, October 3, 2014 - PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" o... | realwire.c... |
02.07.2014 | PAREXEL International Announces Acquisition Of ATLAS Medical... | London, UK, July 2, 2014 – PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Compan... | realwire.c... |
16.06.2014 | PAREXEL Cuts Clinical Trial Start-Up Time For Sponsors By We... | Latest RTSM technology features standardized study components for faster implementation and greater ... | realwire.c... |
27.05.2014 | PAREXEL Names Dr. Sy Pretorius Chief Scientific Officer | To lead integration of Company’s global scientific expertise and services to meet end-to-end custome... | realwire.c... |
20.05.2014 | PAREXEL Launches Perceptive MyTrials® Data-Driven Monitoring... | Technology solution designed to improve monitoring effectiveness and efficiency
LONDON, UK, 20th May... | realwire.c... |
27.12.2012 | CRO’s $72M software acquisition boosts its informatics muscl... | “We are solving many of the problems for our space that eventually need to be solved for the broader... | medcitynew... |
23.04.2012 | What Dennis Gillings told me about Quintiles during a chance... | “Oh, we’re dead in the water, I’m afraid,” he deadpanned.
Far from it. The company that Gillings lau... | medcitynew... |
01.03.2012 | INC Research tops CRO quality ranking as M&A shapes phar... | Before acquiring Kendle last year, INC was a mid-sized CRO whose size and pharmaceutical outsourcing... | medcitynew... |
23.12.2011 | A clinical research organization wish list for Christmas (an... | A strategic partner: The biggest CROs such as, Quintiles, PPD, and Covance (NYSE:CVD) are increasing... | medcitynew... |
14.06.2011 | Mid-sized CROs perform as good or better than larger ones, s... | Kevin Olson, CEO of ISR, said that the survey responses and data do not show why mid-sized CROs as a... | medcitynew... |
05.10.2010 | Parexel opens another office in Japan | Parexel International Corp. (NSDQ:PRXL) brought the number of its offices in Japan to three with the... | massdevice... |
10.08.2010 | Parexel International ends fiscal 2010 in the black | Parexel International Corp. (NSDQ:PRXL) wrapped up its fiscal 2010 reporting a 19.4 percent increase... | massdevice... |
26.01.2010 | Q2 less than perfect for Parexel | Restructuring costs cut deeply into second-quarter profits at Parexel International Corp. (NSDQ:PRXL... | massdevice... |
- | What’s coming up at MedCity INVEST Precision Medicine Day 3?... | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and li... | medcitynew... |
- | Mid-sized CROs perform as good or better than larger ones, s... | Pharmaceutical companies evaluating which clinical research organizations to work with might want to... | medcitynew... |
- | What Dennis Gillings told me about Quintiles during a chance... | Dennis Gillings doesn’t give many interviews and today, the day his Quintiles successor was announce... | medcitynew... |
- | The evolution of functional service provider (FSP) models | Clinical development outsourcing is evolving. While functional service provider (FSP) models have be... | statnews.c... |
- | Drug development is too slow and too costly. Four key innova... | It’s one of the most talked about issues in healthcare: the future of drug development.
Signs that t... | statnews.c... |
- | INC Research tops CRO quality ranking as M&A shapes phar... | Among clinical research organizations, INC Research is not the biggest, but by at least one measure,... | medcitynew... |
- | Delivering on the promise of more inclusive clinical trials | The pharmaceutical industry is placing new emphasis on making clinical trials more inclusive and div... | statnews.c... |
- | The future of clinical trials is now | By making it easier for patients to participate in research today, Parexel’s Decentralized Clinical ... | statnews.c... |
- | CRO’s $72M software acquisition boosts its informatics muscl... | As contract research organization consolidation continues, one of the oldest CROs, Parexel, has made... | medcitynew... |
- | Is the future of the pharmaceutical industry sustainable? Fo... | As the pharmaceutical industry continues to wrestle with questions around long-term sustainability, ... | statnews.c... |
- | A clinical research organization wish list for Christmas (an... | North Carolina clinical research organization PPD got an early Christmas present with the completion... | medcitynew... |